Characterization of a gyrB mutation responsible for low-level nalidixic acid resistance in Neisseria gonorrhoeae.

doi:10.1128/AAC.35.4.622

Back to search

Article

Characterization of a gyrB mutation responsible for low-level nalidixic acid resistance in Neisseria gonorrhoeae.

Antimicrobial agents and chemotherapy - 1 Apr 1991

Stein D C, Danaher R J, Cook T M

Abstract excerpt

Nalidixic acid-resistant derivatives of Neisseria gonorrhoeae WR302 were identified and categorized into two classes on the basis of their susceptibilities to this antimicrobial agent. The MIC of nalidixic acid for the derivative strain MUG116 was fourfold greater than that for its isogenic paren...

Topics

Amino Acid Sequence
Base Sequence
Cloning, Molecular
DNA, Bacterial
Drug Resistance, Microbial
Molecular Sequence Data
Mutation
Nalidixic Acid
Neisseria gonorrhoeae

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.